0001104659-24-116977.txt : 20241112 0001104659-24-116977.hdr.sgml : 20241112 20241112180108 ACCESSION NUMBER: 0001104659-24-116977 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241107 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stark David Matthew CENTRAL INDEX KEY: 0001722360 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39294 FILM NUMBER: 241450354 MAIL ADDRESS: STREET 1: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Assertio Holdings, Inc. CENTRAL INDEX KEY: 0001808665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850598378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: (224) 419-7106 MAIL ADDRESS: STREET 1: 100 S. SAUNDERS ROAD STREET 2: SUITE 300 CITY: LAKE FOREST STATE: IL ZIP: 60045 4 1 tm2428139-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-11-07 0 0001808665 Assertio Holdings, Inc. ASRT 0001722360 Stark David Matthew ASSERTIO HOLDINGS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045 1 0 0 0 0 Common Stock 2024-11-07 4 A 0 53750 0 A 53750 D Stock Option (right to buy) 1.01 2024-11-07 4 A 0 81225 0 A 2034-11-07 Common Stock 81225 81225 D Restricted stock units were granted on the date of Mr. Stark's initial appointment to the Issuer's Board of Directors in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy. One-third of these restricted stock units are scheduled to vest on each of November 7, 2025, 2026 and 2027, assuming continued service through the applicable vesting date. Stock options were granted on the date of Mr. Stark's initial appointment to the Issuer's Board of Directors in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy. One-third of these stock options are scheduled to vest on each of November 7, 2025, 2026 and 2027, assuming continued service through the applicable vesting date. These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities. /s/ Sam Schlessinger, Attorney-in-fact for David M. Stark 2024-11-12